from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3422c/-

LFCtreatmentdescriptionclass of inhibitor

-1.606

Amikacinug/mL Amikacintranslation

-0.875

Cap5-10ug/mL Capreomycintranslation

-0.940

Rox10-50 ug/mL Roxithromycintranslation

-0.233

SM2-5 ug/mL Streptomycintranslation

-1.161

Tet5-10 ug/mL Tetracyclinetranslation

-1.249

Rif0.2-5ug/mL Rifampicintranscription

-0.659

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.284

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.720

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.115

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.559

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.091

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.995

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.603

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.665

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.279

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.519

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.051

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.580

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.127

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.871

KCN5-20 ug/mL Potassium cyaniderespiration

-0.087

NaN30.2-2 mM Sodium aziderespiration

-0.159

Nigericin50 uM Nigericinrespiration

0.874

TRC10-150 ug/mL Triclosanrespiration

-0.970

TRZ10-25 ug/mL Thioridazinerespiration

1.331

Valinomycin0.5-10 uM Valinomycinrespiration

-0.415

ZnSO42 mM ZnSO4respiration

-0.022

menadione6-10 ug/mL Menadionerespiration

-0.246

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.010

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.206

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.399

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.365

NRP_1Non-replicating persistence stage 1dosRassociated

0.199

Amp0.2mg/mL AmpicillincellWall

0.015

Cephalexin20-100 ug/mL CephalexincellWall

0.034

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.478

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.161

EMB10-20 ug/mL EthambutolcellWall

-0.011

Eta12-40 ug/mL EthionamidecellWall

-0.078

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.281

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.578

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.577

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.197

BZA0.12 mg/mL BenzamidearomaticAmides

-0.034

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.395

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.294

H2O24 mM hydrogen peroxideDNAdamaging

-0.311

Levo10 ug/mL LevofloxacinDNAdamaging

-0.231

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.089

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.254

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.143

UVUV-irradiationDNAdamaging

-0.616

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.290

Antimycin12.5-50 ug/mL Antimycin A?

0.161

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.028

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.304

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.927

PA8240.2-2 ug/mL PA-824?

1.391

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.558

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.388

Verapamil50 uM Verapamil?

-1.155

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.145

methoxatin10-20 ug/mL Methoxatin?